ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maine » Psychiatry

Top Psychiatry Prescribers in Maine

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ELLIOTT GRUEN DO

Psychiatry

6,075

$636K

302
47 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $107

THOMAS SNEED MD

Psychiatry

5,966

$697K

355
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$117
Average prescription price

Avg: $107

BRUCE BLACKMAN D.O.

Psychiatry

4,662

$380K

324
170 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $107

MARI COCHRAN MD

Psychiatry

4,464

$389K

234
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$87
Average prescription price

Avg: $107

ARLENE ALMAZAN MD

Psychiatry

4,328

$723K

152
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$167
Average prescription price

Avg: $107

ROBERT CROSWELL MD

Psychiatry

4,208

$388K

249
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $107

SUBHADEEP BARMAN M.D.

Psychiatry

3,980

$435K

346
27 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$109
Average prescription price

Avg: $107

COLIN POPE MD

Psychiatry

3,731

$253K

255
63 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $107

KEVIN MULLARKY MD

Psychiatry

3,413

$323K

290
43 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$95
Average prescription price

Avg: $107

ROBERT MCCARLEY MD

Psychiatry

3,310

$348K

151
0 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $107

FRED RISSER M.D.

Psychiatry

3,228

$338K

197
35 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $107

MITCHELL PULVER M.D.

Psychiatry

3,150

$334K

212
60 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $107

PAUL MINOT MD

Psychiatry

3,134

$275K

163
21 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$88
Average prescription price

Avg: $107

ARTHUR DINGLEY D.O.

Psychiatry

3,130

$376K

177
21 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$120
Average prescription price

Avg: $107

ROBERT HAINES M.D.

Psychiatry

3,042

$249K

184
20 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $107

ROBERT ANDERSON MD

Psychiatry

2,931

$306K

157
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $107

CHARLES HANSON MD

Psychiatry

2,890

$274K

135
42 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 25%

$95
Average prescription price

Avg: $107

CINDY BOYACK MD

Psychiatry

2,701

$274K

113
20 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$101
Average prescription price

Avg: $107

JAMES BURNETT MD

Psychiatry

2,669

$269K

111
17 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$101
Average prescription price

Avg: $107

VIJAY AMARENDRAN MD

Psychiatry

2,611

$329K

292
37 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 25%

$126
Average prescription price

Avg: $107

ROSALIND GOLD MD

Psychiatry

2,588

$294K

127
14 are 65+

18%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$114
Average prescription price

Avg: $107

ABHAY SINGH MD

Psychiatry

2,572

$218K

185
51 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $107

JENNIFER PARENT M.D.

Psychiatry

2,433

$323K

108
14 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $107

STEVEN STOUT MD

Psychiatry

2,341

$313K

136
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$134
Average prescription price

Avg: $107

DAVID LOBOZZO MD

Psychiatry

2,304

$284K

133
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $107

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank